Genentech, a member of the Roche Group, has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility in Holly Springs, NC. The project will add more than 400 high-wage manufacturing jobs when the site is operational and more than 1,500 construction jobs during site development. The new facility will ultimately support Roche and Genentech’s future portfolio of next-generation obesity medicines, and this initial investment could expand in the fut...